Cargando…
Indirect comparison of efficacy and safety of chiglitazar and thiazolidinedione in patients with type 2 diabetes: A meta-analysis
BACKGROUND: Chiglitazar is an emerging pan-agonist of all peroxisome proliferator activated receptors (PPAR)-α, δ and γ, and has therapeutic potential for type 2 diabetes (T2D). However, to date, no clinical studies or meta-analyses have compared the efficacy and safety of chiglitazar and traditiona...
Autores principales: | Lin, Chu, Li, Zong-Lin, Cai, Xiao-Ling, Hu, Sui-Yuan, Lv, Fang, Yang, Wen-Jia, Ji, Li-Nong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642417/ https://www.ncbi.nlm.nih.gov/pubmed/37970134 http://dx.doi.org/10.4239/wjd.v14.i10.1573 |
Ejemplares similares
-
Efficacy and safety of argatroban in treatment of acute ischemic stroke: A meta-analysis
por: Lv, Bin, et al.
Publicado: (2022) -
Efficacy and Safety of Novel Thiazolidinedione Rivoglitazone in Type-2 Diabetes a Meta-Analysis
por: Dutta, Deep, et al.
Publicado: (2023) -
Thiazolidinediones versus metformin on improving abnormal liver enzymes in patients with type 2 diabetes mellitus: a meta-analysis
por: Xu, Chunmei, et al.
Publicado: (2018) -
Comparison of Placebo Effect between Asian and Caucasian Type 2 Diabetic Patients: A Meta-Analysis
por: Guo, Wei, et al.
Publicado: (2018) -
Efficacy and safety of regorafenib as beyond second-line therapy in patients with metastatic colorectal cancer: an adjusted indirect meta-analysis and systematic review
por: Wu, Yinying, et al.
Publicado: (2020)